BIOGEN PHARMACHEM INDUSTRIES L (BIOGEN)

BSE: ₹0.35
Stock Performance
Corporate Announcements
2026-06-12 17:30:26
Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026.

This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 14th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2026. 2.) Independent Auditor’s Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2026. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2026 with “Unmodified Opinion”. The board meeting commenced at 04.00 PM and concluded at 04:30 PM. We request you to kindly take on record the same. Thanking You.

2026-05-14 16:42:47

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 0.75 0.00 0.00 0.00 -0.09 0.00 0.00 1.35 1.54 0.00 0.00 0.58
YOY Revenue Growth % - - - - -112.07% - - - - - - -57.24%
Other Income 0.00 0.76 0.09 0.78 0.00 -0.65 0.23 0.00 0.00 -0.10 0.54 0.00
Total Income 0.75 0.76 0.09 0.78 -0.09 -0.65 0.23 1.35 1.54 -0.10 0.54 0.58
Total Expenses + 0.35 0.04 0.03 0.04 0.07 0.35 0.54 0.17 0.20 0.39 0.08 0.94
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 0.05 0.01 0.01 0.01 0.01 0.01 0.05 0.09 0.06 0.05 0.07 0.10
Other Expenses 0.29 0.03 0.02 0.02 0.05 0.34 0.49 0.08 0.13 0.34 0.01 0.83
Operating Profit 0.41 -0.04 -0.03 -0.04 -0.16 -0.35 -0.54 1.18 1.34 -0.39 -0.08 -0.36
OPM % 54% 0% 0% 0% 0% 0% 0% 87.1% 87.2% 0% 0% -62.1%
Profit Before Tax + 0.41 0.72 0.06 0.74 -0.16 -1.00 -0.31 1.18 1.34 -0.49 0.46 -0.36
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax % 0% 0% 0% 0% - - - 0% 0% - 0% -
Profit After Tax 0.41 0.72 0.06 0.74 -0.16 -1.00 -0.31 1.18 1.34 -0.49 0.46 -0.36
EPS (Basic) 0.01 0.02 0.00 0.00 0.00 -0.02 0.00 0.02 0.01 -0.01 0.01 0.00

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 2.56 0.84 0.00 0.83 2.16 1.62
YOY Revenue Growth % 205.1% - -100% -61.69% 33.24% -
Other Income 0.00 0.00 2.38 0.00 0.01 -1.61
Total Income 2.56 0.84 2.38 0.83 2.17 0.01
Total Expenses + 1.60 1.13 0.45 0.37 2.18 1.62
Cost of Materials Consumed 0.00 0.00 0.00 0.00 2.01 1.48
Employee Benefit Expense 0.28 0.17 0.08 0.17 0.05 0.01
Other Expenses 1.32 0.96 0.37 0.20 0.11 0.12
Operating Profit 0.96 -0.29 -0.45 0.46 -0.02 0.00
OPM % 37.4% -34.9% 0% 55% -0.7% 0.3%
Profit Before Exceptional 0.96 -0.29 1.93 0.46 -0.01 -1.60
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 0.96 -0.29 1.93 0.46 -0.01 -1.60
Tax Expense 0.10 0.00 0.00 0.00 0.00 0.00
Tax % 10.2% - 0% 0% - -
Profit After Tax 0.86 -0.29 1.93 0.46 -0.01 -1.60
EPS (Basic) 0.01 0.00 0.00 0.01 0.00 -0.02

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 98.91 89.36 56.75 54.60 53.02 51.69
Property, Plant & Equipment 0.00 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 32.78 23.84 5.44 8.85 6.95 9.49
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 0.49 2.66 0.07 0.15 1.93 2.50
Inventories 0.00 0.00 0.00 0.00 0.00 0.00
Trade Receivables 0.00 0.00 0.00 0.00 0.00 2.48
Cash and Cash Equivalents 0.32 0.05 0.01 0.01 0.00 0.01
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 99.09 91.93 56.52 54.59 54.13 54.14
Equity Share Capital 90.26 65.26 65.26 65.26 65.26 65.26
Other Equity 8.83 26.67 -8.74 -10.67 -11.13 -11.12
Non-Current Liabilities 0.10 0.00 0.00 0.00 0.00 0.00
Current Liabilities 0.21 0.09 0.30 0.15 0.82 0.05
Total Liabilities 0.31 0.09 0.30 0.15 0.82 0.05

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 1.57 -1.09 1.97 1.63 1.40 3.95
Cash from Investing Activities -9.56 -32.61 -2.08 -1.58 -1.32 -3.64
Cash from Financing Activities 6.30 35.70 0.00 0.00 0.00 -0.31
Net Increase/Decrease in Cash -1.69 2.00 -0.11 0.05 0.08 0.00